bioMérieux: raises annual targets.
(CercleFinance.com) - In light of its performance over the first six months of the year, bioMérieux now targets organic sales growth of between 9% and 10%, with underlying contributory operating profit of between 330 million and 345 million euros.
The specialist of in-vitro diagnosis reported H1 earnings that are up 18% at 101 million euros, with underlying contributory operating profit that is up 15.4% to 172 million euros, meaning a 0.3-point improvement in its corresponding margin to 15.2%.
bioMérieux's revenues reached 1,134 million euros, up 13.3%. Like-for-like growth reached 11.3%, benefiting from the balanced contribution between BioFire FilmArray and other strategic ranges.
Copyright (c) 2017 CercleFinance.com. All rights reserved.
The specialist of in-vitro diagnosis reported H1 earnings that are up 18% at 101 million euros, with underlying contributory operating profit that is up 15.4% to 172 million euros, meaning a 0.3-point improvement in its corresponding margin to 15.2%.
bioMérieux's revenues reached 1,134 million euros, up 13.3%. Like-for-like growth reached 11.3%, benefiting from the balanced contribution between BioFire FilmArray and other strategic ranges.
Copyright (c) 2017 CercleFinance.com. All rights reserved.